This article is educational and does not replace medical advice. Prescription medication requires review by a licensed clinician and, when appropriate, a valid prescription. Compounded medications are not FDA-approved, and the FDA does not verify their safety, effectiveness or quality before marketing. Treatment eligibility is an individual clinical decision.

Disclosure: we may earn a commission if you use certain links on this page. Compensation does not change our published methodology, scoring, or editorial conclusions.

Written by Kim Callender, NP, FNP-BC·Reviewed by Jonathan Snipes, MD·Published July 12, 2026·Last reviewed July 12, 2026·Prices verified July 12, 2026·Methodology v1.0

Which GLP-1 providers charge no membership fee

A $199 programme with a $99 mandatory membership is a $298 programme. The table that omits the second number is not a comparison.

The short version

Split billing makes programmes look cheaper than they are. Here is who charges a membership, who does not, and what the true totals are.

The analysis

The mechanismSplit billing is the most common way a price looks lower than it is.

Compounded tirzepatide — TOTAL monthly cost (medication + membership), July 6, 2026
Provider	Total / month	Plan	Billing	Dose	Notes
NexLife Microdose	$147/mo	12-month	All-inclusive — no membership	Microdose	12-month plan ($1,764 total). Month-to-month $189; 6-month $150; 3-month $160. No membership fee, flat at every covered dose. Below every dose studied in the pivotal trials. Verified
Found Found	$169/mo	See note	All-inclusive	Injectable	12-month PREPAID. Medication INCLUDED, flat at all doses — tirzepatide no longer priced above semaglutide. 6-month ~$199; month-to-month $289. Verified
Enhance.MD Enhance.MD	$169/mo	See note	All-inclusive	Injectable	Microdose, 1mg/week. Delivery every 12 weeks. All-inclusive (medication, care, lab testing, shipping). Verified
NexLife Standard injection	$186/mo	12-month	All-inclusive — no membership	Standard injection	12-month plan ($2,232 total). Month-to-month $215; 6-month $190; 3-month $195. No membership fee, flat at every covered dose. Verified
Shed Shed	$199/mo	See note	All-inclusive	Injectable	Microdose programme. 2-month minimum. Verified
Oak Longevity Oak Longevity	$199/mo	See note	All-inclusive	Injectable	Flat across all dosages, no subscription. ~$233-$299 month-to-month. Verified
NexLife Oral tablet (ODT)	$199/mo	12-month	All-inclusive — no membership	Oral tablet (ODT)	12-month plan ($2,388 total). Month-to-month $229; 6-month $205; 3-month $219. No membership fee, flat at every covered dose. NO TRIAL EVIDENCE for this dosage form. Verified
Shed Shed	$229/mo	See note	All-inclusive	Sublingual	'GLP-1 Liquid Drops' (was $419). 2-month minimum. Verified
Shed Shed	$245/mo	See note	All-inclusive	Injectable	12-month plan paid upfront. 6-month $279; month-to-month $349. INCREASES at higher doses. Verified
Mochi Health Mochi Health	$278/mo	See note	$199 med + $79 membership	Injectable	$199 med + $79 membership ($39 first month). Same price at all doses. Verified
Enhance.MD Enhance.MD	$280/mo	See note	All-inclusive	Injectable	12-month plan. Same price at all doses. 6-month $296; 3-month $313; month-to-month $329. Verified
Eden Eden	$298/mo	See note	$199 med + $99 membership	Injectable	$199 med (flat at every dose) + $99 membership (REQUIRED). Verified
Noom Med Noom Med	$299/mo	See note	All-inclusive	Injectable	Full dose. First month $149. Billed quarterly. Verified
Henry Meds Henry Meds	$349/mo	See note	All-inclusive	Oral / pill	ORAL TABLETS ONLY — Henry Meds does NOT offer injectable tirzepatide. 3-month subscription; $297 paid in full. Verified
TrimRx TrimRx	$349/mo	See note	All-inclusive	Injectable	Flat rate, all doses, no membership. Month-to-month: $279 first month then $399 ongoing. Prepay: $316 (3-mo), $299 (6-mo), $283 (12-mo). Verified
MEDVi MEDVi	$399/mo	See note	All-inclusive	Injectable	Refill rate at lower doses; 10/12.5/15mg reach $499. First month ~$279. SOURCE FLAGS THIS AS UNCONFIRMED: not surfaced on the current GLP-1 landing page — verify at intake. Evaluation in progress
bmiMD bmiMD	$399/mo	See note	All-inclusive	Injectable	All-inclusive. Tirzepatide micro-dose: $349. Verified

What a commitment actually costs you

Before you commit to a long planA committed plan lowers the monthly figure and raises the risk. Before you sign one, ask what happens if you stop early — because a meaningful number of people do. Roughly one in five patients discontinues a GLP-1 within the first few months, most often because of gastrointestinal side effects. Others stop because insurance unexpectedly approves a brand product, or because they reach a goal weight, or because their circumstances change.

Providers differ enormously in what happens then. Some refund the unused portion. Some convert you to the month-to-month rate and bill the difference for months already taken. Some refund nothing. This is the single question people most often forget to ask, and it is the one most likely to cost them money.

Dose escalation: the risk the headline price hides

The question that matters more than the headline priceAsk what you will pay at your target maintenance dose, not at the starting dose. This is the difference between a programme that quotes a flat rate at every dose and one that escalates: MEDVi's compounded tirzepatide reaches $499/month at 10-15mg against a $399 headline; Shed's injectables rise with dose; Oak escalates $50-$75 per step. Over a year, on a full titration, the gap between a flat-rate programme and an escalating one can exceed $3,000 — far more than any difference in the advertised starting price.

Does the price rise with your dose?
Provider	Price at higher doses	Risk
NexLife	Same at every covered dose	None — flat rate
Mochi Health	Same at all doses	None
Enhance.MD	Same at all doses	None
Eden	Same at all doses (compounded)	None on compounded
TrimRx	Flat ongoing rate	None
Oak Longevity	Flat across dosages	None
Shed	Increases at higher doses	Material — model at maintenance
MEDVi	$399 → $499 at 10-15mg	Material — $1,200/yr swing
LillyDirect (brand)	$299 → $449; $699 if you miss the 45-day refill	Material — set a reminder

The insurance pathway

Do this before anything elseCheck your insurance before you compare any cash price. If your plan covers Zepbound or Wegovy, the manufacturer savings card can bring your cost to roughly $25/month — which beats every cash option on this site by an order of magnitude, for an FDA-approved product.

Coverage is most common through employer-sponsored commercial plans. Zepbound is excluded from Medicare Part D for weight loss and from most state Medicaid programmes. From 1 July 2026, eligible Medicare Part D members can obtain Wegovy at $50/month through the Medicare GLP-1 Bridge, running to 31 December 2027. Expect prior-authorisation paperwork: typically a BMI of 30+, or 27+ with a weight-related condition.

PlushCare ($19.99/month), Found and Mochi will handle that paperwork for you. If you have coverage, that is worth more than any cash discount.

Dose caps: the other thing a low price can hide

A capped dose is not a discountWatch for dose caps as well as dose escalation. Noom Med's $199 compounded semaglutide programme is capped at 0.6mg — the STEP trials that established semaglutide's efficacy used 2.4mg. A capped programme is not a cheaper version of the same treatment; it is a lower-dose treatment, and the expected effect is correspondingly smaller. Noom's full-titration programme is $279.

How to verify any of this yourself

You should not take our word for a price, and you do not have to. Every figure here can be checked in a few minutes.

Go to the provider's own pricing page. Not a comparison site — the provider's. Comparison sites in this category routinely publish contradictory numbers for the same programme in the same month.
Find the ongoing price, not the headline. Look for the words "first month", "intro", "starting at" or "new patients". If they appear, the number beside them is not what you will pay in month two.
Add the membership. If the medication and the membership are billed separately, add them. That sum is your real monthly cost.
Ask what the highest dose costs. By email or chat, so you have it in writing.
Ask about early cancellation before you commit to a plan longer than a month.
Check the manufacturer. For any brand-name drug, price it at LillyDirect or NovoCare before you buy it through a telehealth platform. Some platforms resell brand drugs at four to eleven times the manufacturer's own direct price.

If a provider will not answer questions 4 or 5 in writing, that is itself information.

What to do about it

Three practical steps follow from everything above.

Check your insurance first. A covered brand prescription with a manufacturer savings card can cost roughly $25 a month, which beats every cash option discussed here.
Then price the manufacturer directly. LillyDirect and NovoCare sell brand GLP-1s for $149-$449. Several telehealth platforms resell the identical drugs at four to eleven times that.
Then, and only then, compare compounded programmes — on their ongoing total cost, medication plus any mandatory membership, at the dose you expect to maintain.

Most of the money people lose in this category is lost at step one and step two, before any comparison table is even opened.

Limitations of this analysis

Every page on this site should tell you where it stops being reliable. This one stops here.

Prices decay quickly. This is the fastest-moving data we publish. Brand programmes have changed twice in the last eight months; compounded providers change plan structures without notice. Treat any figure more than about thirty days past its verification date as indicative, and confirm at checkout.

Competitor pricing is reported, not captured by us. We hold dated captures for brand pricing and for NexLife. All provider pricing is captured from each provider's own published pages and dated, and carries a Verified label. Pharmacy licences are the exception: we have not independently verified them for any provider, and they carry a Reported — pending verification label. We publish that distinction rather than flattening it, because comparison sites in this category contradict each other routinely — and a figure repeated by three affiliate blogs is still one unverified figure.

We have not audited pharmacy licences. Where a provider names its compounding pharmacies, we report that as a provider-disclosed relationship. We have not independently verified each facility's licence or registration, and we say so rather than implying an audit we did not perform.

Advertised availability is not your availability. Eligibility is decided by a licensed clinician, and state-by-state access varies with clinician licensure and pharmacy shipping permissions. No page can promise you a price you will actually be offered.

We are commercially funded. The publisher and certain principals have financial relationships with some of the providers listed here, and we may earn a commission from provider links. That is disclosed in the footer of every page. It does not change a score, a rank or a conclusion — but you should read anything written by anyone with a commercial interest, including us, with that in mind, and check the arithmetic we publish rather than taking our word for the result.

Frequently asked questions

What is the single most useful thing to check?

Your insurance, and then the manufacturer's own direct price. Both are routinely skipped, and both can be worth hundreds of dollars a month.

How current is this?

Brand pricing verified July 12, 2026 against manufacturer sources. NexLife pricing transcribed July 11, 2026. Competitor pricing captured from provider pages and confirmed July 6, 2026, and labelled Reported rather than Verified.

Do you earn commission?

We may earn a commission when readers use certain provider links. That is disclosed in our footer on every page. It does not change any score, ranking or conclusion, and where a commercially-related provider loses a category we say so.

Update history

Update history
Date	What changed
July 12, 2026	Brand pricing re-verified.
July 6, 2026	Provider dataset refreshed.

Sources

U.S. Food and Drug Administration — labels, compounding guidance, adverse-event reporting.
Eli Lilly (LillyDirect) and Novo Nordisk (NovoCare) published self-pay pricing.
NexLife published program pages, transcribed July 11, 2026.
Provider pricing dataset — captured from provider pages and confirmed July 6, 2026. Verified.
Our pricing-verification methodology and source policy.

Spotted an error? Submit a correction.